Jefferies Financial Group Inc. Makes New $440,000 Investment in Avita Medical Inc. $RCEL

Jefferies Financial Group Inc. acquired a new stake in shares of Avita Medical Inc. (NASDAQ:RCEL – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 37,500 shares of the company’s stock, valued at approximately $440,000.

A number of other large investors have also made changes to their positions in RCEL. BlackRock Inc. bought a new position in Avita Medical during the second quarter valued at about $2,333,000. NewEdge Advisors LLC lifted its position in shares of Avita Medical by 71.4% in the 2nd quarter. NewEdge Advisors LLC now owns 148,931 shares of the company’s stock worth $615,000 after acquiring an additional 62,046 shares during the period. Bank of America Corp DE lifted its position in shares of Avita Medical by 145.3% in the 1st quarter. Bank of America Corp DE now owns 62,128 shares of the company’s stock worth $230,000 after acquiring an additional 36,799 shares during the period. Ieq Capital LLC bought a new stake in shares of Avita Medical in the 2nd quarter worth approximately $134,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Avita Medical during the 2nd quarter worth approximately $95,000. Institutional investors and hedge funds own 27.66% of the company’s stock.

Avita Medical Price Performance

Shares of RCEL stock opened at $15.63 on Monday. The stock’s fifty day simple moving average is $13.40 and its 200 day simple moving average is $7.16. The firm has a market cap of $491.09 million, a price-to-earnings ratio of -13.25 and a beta of 2.03. Avita Medical Inc. has a one year low of $3.22 and a one year high of $18.43.

Avita Medical (NASDAQ:RCEL – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.04. The company had revenue of $26.11 million during the quarter, compared to the consensus estimate of $22.35 million. On average, research analysts anticipate that Avita Medical Inc. will post -0.94 earnings per share for the current year.

Analyst Ratings Changes

RCEL has been the topic of a number of research reports. Lake Street Capital boosted their price objective on Avita Medical from $12.00 to $20.00 and gave the company a “buy” rating in a research report on Friday, November 6th. Weiss Ratings restated a “sell (e+)” rating on shares of Avita Medical in a research note on Monday, September 21st. BTIG Research raised their target price on Avita Medical from $15.00 to $21.00 and gave the stock a “buy” rating in a research report on Friday, November 6th. Wall Street Zen upgraded shares of Avita Medical from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, TD Cowen lifted their price target on shares of Avita Medical from $20.00 to $22.00 and gave the stock a “buy” rating in a research note on Thursday. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Avita Medical has an average rating of “Moderate Buy” and a consensus target price of $16.60.

Read Our Latest Stock Report on Avita Medical

Avita Medical Company Profile

(Free Report)

AVITA Medical is a regenerative medicine company focused on treatments for skin restoration. Its flagship technology, the RECELL System, enables clinicians to use a small sample of a patient’s healthy skin to prepare a suspension of skin cells for application to wounds. The company’s RECELL products are used in the treatment of burns and certain other skin injuries, including full-thickness skin defects. The approach is intended to support wound coverage while reducing the amount of donor skin needed compared with conventional skin-grafting procedures.

Further Reading

Want to see what other hedge funds are holding RCEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avita Medical Inc. (NASDAQ:RCEL – Free Report).

Institutional Ownership by Quarter for Avita Medical (NASDAQ:RCEL)

Receive News & Ratings for Avita Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avita Medical and related companies with MarketBeat.com's FREE daily email newsletter.